Evidence map›Paper›PMID 30190607›Full record

ArticleGene therapy2018

Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization.

Peirong Hu, Yanmin Bi, Hong Ma, Thipparat Suwanmanee, Brian Zeithaml, Nate J Fry, Donald B Kohn, Tal Kafri

Abstract read
In one paragraph

Article in Gene therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Peirong HuGene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Yanmin BiGene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Hong MaGene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Thipparat SuwanmaneeGene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Brian ZeithamlGene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Nate J FryGene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Donald B KohnDepartment of Microbiology, Immunology and Molecular Genetics, and Pediatrics, University of California, Los Angeles, CA, 90095, USA.ORCID http://orcid.org/0000-0003-1840-6087
Tal KafriGene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. kafri@med.unc.edu.
University of North Carolina at Chapel Hill · USUniversity of California, Los Angeles · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Nonintegrating Lentiviral Vectors Towards Clinical TrialsR01DK058702 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAFRI, TAL · 2001 to 2019
$5.0M
Lentiviral Vector-Based Gene Therapy and The Host Genetic BackgroundR01HL128119 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAFRI, TAL · 2015 to 2018
$3.0M
NCI NIH HHS P30 CA016086NHLBI NIH HHS R01 HL128119NIDDK NIH HHS R01 DK058702NIH HHS 5R01DK058702NIH HHS R01-HL128119
6 · The paper itself

Abstract

Lentiviral vector mobilization following HIV-1 infection of vector-transduced cells poses biosafety risks to vector-treated patients and their communities. The self-inactivating (SIN) vector design has reduced, however, not abolished mobilization of integrated vector genomes. Furthermore, an earlier study demonstrated the ability of the major product of reverse transcription, a circular SIN HIV-1 vector comprising a single- long terminal repeat (LTR) to support production of high vector titers. Here, we demonstrate that configuring the internal vector expression cassette in opposite orientation to the LTRs abolishes mobilization of SIN vectors. This additional SIN mechanism is in part premised on induction of host PKR response to double-stranded RNAs comprised of mRNAs transcribed from cryptic transcription initiation sites around 3'SIN-LTR's and the vector internal promoter. As anticipated, PKR response following transfection of opposite orientation vectors, negatively affects their titers. Importantly, shRNA-mediated knockdown of PKR rendered titers of SIN HIV-1 vectors comprising opposite orientation expression cassettes comparable to titers of conventional SIN vectors. High-titer vectors carrying an expression cassette in opposite orientation to the LTRs efficiently delivered and maintained high levels of transgene expression in mouse livers. This study establishes opposite orientation expression cassettes as an additional PKR-dependent SIN mechanism that abolishes vector mobilization from integrated and episomal SIN lentiviral vectors.

Indexed as

AnimalsGenetic VectorsGenome, ViralHIV-1HIV InfectionsHIV Long Terminal RepeatHumansLentivirusMiceRNA, Double-StrandedRNA, Small InterferingRNA, Double-StrandedRNA, Small Interfering

Identifiers

PMID30190607
PMCPMC6478381
OpenAlexW2890348780

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.